NimbleGen raises $12.75 Million in VC Funding

NimbleGen Systems has raised $12.75 million in a series F round of venture capital financing, the company said this week.

Current investors Baird Venture Partners and Venture Investors led the round. New investors included Cargill Ventures and Topspin Partners, as well as all of the company’s other existing venture capital and institutional investors.

The new round brings to $41 million the total amount of private-equity financing NimbleGen has raised since its founding in 2000.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.